Trials / Completed
CompletedNCT05362604
Prenatal Diagnosis of the Fetal Esophageal or Intestinal Atresia
Top Benefits of the Prenatal Diagnosis of the Fetal Esophageal or Intestinal Atresia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 51 (actual)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Aim- to investigate how prenatal diagnosis of fetal esophageal or intestinal atresia impacts obstetric and neonatal outcomes. Methods- This was a retrospective cohort study at a single center. The study population comprised 51 consecutive pregnancies, including 29 mothers (57%) and their fetuses affected by prenatally diagnosed fetal esophageal or intestinal atresia, and 22 mothers (43%) and their babies with postnatally diagnosed fetal esophageal or intestinal atresia.
Detailed description
Aim- to investigate how prenatal diagnosis of fetal esophageal or intestinal atresia impacts obstetric and neonatal outcomes. Methods- This was a retrospective cohort study at a single center. The study population comprised 51 consecutive participants, including 29 mothers (57%) and their fetuses affected by prenatally diagnosed fetal esophageal or intestinal atresia, and 22 mothers (43%) and their babies with postnatally diagnosed fetal esophageal or intestinal atresia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | scheduled delivery at a tertiary center | Neonatal units in French hospitals are classified in three levels. The intention is for infants requiring high level care to receive it in a tertiary neonatal unit within the same network when appropriate. In case of known fetal gastro-intestinal artesia, the prenatal care includes obstetric consultation and level 3 ultrasound scheduled every four weeks at our unit until the end of the pregnancy, antenatal consultations with a specialized multidisciplinary team, and an antenatal visit of the birth center to reduce the parental anxiety. |
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2022-02-07
- Completion
- 2022-02-07
- First posted
- 2022-05-05
- Last updated
- 2022-05-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05362604. Inclusion in this directory is not an endorsement.